With widespread availability and the use of antiretroviral therapy, patients with human immunodeficiency virus (HIV) in the United States are living long enough to experience non-AIDS–defining ...illnesses. HIV is associated with an increased risk for cardiovascular disease (CVD) because of traditional CVD risk factors, residual virally mediated inflammation despite HIV treatment, and side effects of antiretroviral therapy. No United States population-wide studies have evaluated patterns of CVD mortality for HIV-infected subjects. Our central hypothesis was that the proportionate mortality from CVD (CVD mortality/total mortality) in the HIV-infected population increased from 1999 to 2013. We used the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research online database of the United States public health data to assess proportionate CVD mortality from 1999 to 2013 in the HIV-infected, general, and inflammatory polyarthropathy populations; the inflammatory polyarthropathy population was included as a positive control group. Total mortality in the HIV-infected population decreased from 15,739 in 1999 to 8,660 in 2013; however, CVD mortality increased from 307 to 400 during the same period. Thus, proportionate CVD mortality for the HIV-infected population increased significantly from 1999 to 2013 (p <0.0001); this pattern was consistent across races, particularly for men. In contrast, proportionate CVD mortality decreased for the general and inflammatory polyarthropathy populations from 1999 to 2013. In conclusion, CVD has become an increasingly common cause of death in HIV-infected subjects since 1999; understanding evolving mortality risks in the HIV-infected population is essential to inform routine clinical care of HIV-infected subjects as well as CVD prevention and treatment.
Risk Factors for Sudden Cardiac Death in Post-Menopausal Women Bertoia, Monica L., MPH, PhD; Allison, Matthew A., MD, MPH; Manson, JoAnn E., MD, DrPH ...
Journal of the American College of Cardiology,
12/2012, Letnik:
60, Številka:
25
Journal Article
Recenzirano
Odprti dostop
Objectives The aim of this study was to estimate the annual incidence rate of sudden cardiac death (SCD) and to identify risk factors for SCD in post-menopausal women. Background With the aging U.S. ...population, post-menopausal women now have the greatest population burden of cardiovascular disease including SCD. Methods We examined 161,808 women who participated in the Women's Health Initiative clinical trials and observational study. The women were recruited at 40 clinical sites across the United States, enrolled between 1993 and 1998, and followed until August 2009. Our primary endpoint is incident SCD, defined as death occurring within 1 h of symptom onset or within 1 h after the participant was last seen without symptoms and death that occurred in the absence of a potentially lethal non-coronary disease process. Results Four hundred eighteen women experienced adjudicated SCD. The incidence rate of SCD was 2.4/10,000 women/year (95% confidence interval: 2.2 to 2.7). We identified the following independent risk factors for SCD: older age, African-American race, tobacco use, higher pulse, higher waist-to-hip ratio, elevated white blood cell count, history of heart failure, diabetes, history of myocardial infarction, previous carotid artery disease, and hypertension. Population-attributable fractions were greatest for hypertension, waist-to-hip ratio, and myocardial infarction. Conclusions Besides traditional risk factors for coronary heart disease, risk factors for sudden cardiac death in post-menopausal women include African-American race, higher pulse, higher waist-to-hip ratio, elevated white blood cell count, and heart failure. Nearly one-half of women who experienced sudden cardiac death had no previous diagnosis of coronary heart disease.
eReferral Between Hospitals and Quitlines Tindle, Hilary A., MD, MPH; Daigh, Robin, MBA; Reddy, Vivek K., MD ...
American journal of preventive medicine,
October 2016, Letnik:
51, Številka:
4
Journal Article
Abstract The two-stage exchange algorithm is the gold standard for managing chronic periprosthetic joint infection (PJI); this study evaluated the impact of having the stages performed at different ...institutions. Patients with a chronically infected total joint arthroplasty (hip or knee) with initial resection at an outside hospital and subsequent care at our institution (transferred group) were identified then matched with a similar cohort that received both stages at our institution (continuous group). Eighteen patients (transferred group) were compared to 36 matched controls. There were significantly lower rates of successful reimplantation and retention, longer duration of treatment and more procedures in the transferred group compared to the continuous group. Patients transferred during their care for chronic PJI underwent more surgeries, longer treatment times, and less favorable outcomes.
PDF
